Trial Condition(s):

Erectile Dysfunction

Evaluating the efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in subjects with erectile dysfunction (ED)

Bayer Identifier:

11333

ClinicalTrials.gov Identifier:

NCT00663130

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Evaluating the efficacy of 10mg vardenafil versus 10mg tadalafil in the first 45 minutes post-dosing, in an as-required regimen for 4 weeks in subjects with mild/moderate to severe ED

Inclusion Criteria
- Age between 18 and 64 years
 - Heterosexual males
 - Erectile dysfunction for more than 6 months
Exclusion Criteria
- Penile anatomical abnormalities
 - Spinal cord injury
 - History of surgical prostatectomy

Trial Summary

Enrollment Goal
759
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design